The overall goal of this project is to map the distribution of PrPCJD in the human brain in 20 cases of sporadic Creutzfeldt-Jakob disease (CJD) and 20 cases of familial CJD. The great majority, if not all, of the familial CJD cases will be from the Libyan Jew population in which a prion protein gene codon 200 mutation has been genetically linked to dominantly inherited CJD. The histoblot technique will be adapted to large coronal sections of brain to generate comprehensive and detailed maps of the location of PrPCJD deposition and to estimate its regional brain concentration. The extraordinarily high sensitivity and specificity of the histoblot method has proven invaluable for studies of PrPSc infectious scrapie of rodents. New testable hypotheses regarding both the etiology and pathogenesis prion diseases have emerged. The two most relevant and important are: 1) That the pattern of PrPsc accumulation in the brain is the most fundamental characteristic which defines the different cliniconeuropathological syndromes of scrapie arguing that each prion isolate (""""""""strain"""""""") targets different neuron populations for he synthesis of PrPsc and raises the possibility that the information encoded in PrPsc, which determines the characteristics of each prion isolated, are determined by neurons. 2) The neuropathological changes in scrapie colocalize with PrPsc in support of the hypothesis that PrPsc deposition in the brain causes the clinically relevant neuropathology. Because of the great success of histoblot analysis to understanding scrapie, we now want to apply the technique to cases of CJD because there are many issues of human prion diseases which cannot be resolved by studying infectious scrapie in animals. Human CJD is more complex because most of the cases are classified as sporadic, because there are multiple mutations of the prion protein gene linked to different familial prion syndromes and because proven infectious forms are rare. Both the clinical course and severity of neuropathological features of CJD are quite variable. Some objectives of this study are to test whether PrPCJD is only found in prion diseases, whether PrPCJK and neuropathology colocalize, whether their is a diversity of cliniconeuropathological CJD subtypes, and to test whether the neuroanatomic pattern of PrPCJD deposition distinguishes CJD subtypes better than clinical features or the distribution of neuropathology.
| O'Brien, Connor J; Droege, Daniel G; Jiu, Alexander Y et al. (2018) Photoredox Cyanomethylation of Indoles: Catalyst Modification and Mechanism. J Org Chem 83:8926-8935 |
| Condello, Carlo; Lemmin, Thomas; Stöhr, Jan et al. (2018) Structural heterogeneity and intersubject variability of A? in familial and sporadic Alzheimer's disease. Proc Natl Acad Sci U S A 115:E782-E791 |
| Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49-63 |
| Yang, Bing; Wu, Haifan; Schnier, Paul D et al. (2018) Proximity-enhanced SuFEx chemical cross-linker for specific and multitargeting cross-linking mass spectrometry. Proc Natl Acad Sci U S A 115:11162-11167 |
| Irimata, Katherine E; Dugger, Brittany N; Wilson, Jeffrey R (2018) Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes. Curr Alzheimer Res 15:1032-1044 |
| Nick, Mimi; Wu, Yibing; Schmidt, Nathan W et al. (2018) A long-lived A? oligomer resistant to fibrillization. Biopolymers 109:e23096 |
| Woerman, Amanda L; Watts, Joel C; Aoyagi, Atsushi et al. (2018) ?-Synuclein: Multiple System Atrophy Prions. Cold Spring Harb Perspect Med 8: |
| Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) Familial Parkinson's point mutation abolishes multiple system atrophy prion replication. Proc Natl Acad Sci U S A 115:409-414 |
| Johnson, Noah R; Condello, Carlo; Guan, Shenheng et al. (2017) Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice. Proc Natl Acad Sci U S A 114:E11029-E11036 |
| Gerkin, Richard C; Adler, Charles H; Hentz, Joseph G et al. (2017) Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype. Ann Clin Transl Neurol 4:714-721 |
Showing the most recent 10 out of 363 publications
